Description: Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
Home Page: www.evokepharma.com
EVOK Technical Analysis
420 Stevens Avenue
Solana Beach,
CA
92075
United States
Phone:
858 345 1494
Officers
| Name | Title |
|---|---|
| Mr. David A. Gonyer | Co-Founder, CEO, Pres & Director |
| Mr. Matthew J. D'Onofrio | Co-Founder, Chief Bus. Officer, Exec. VP, Treasurer & Sec. |
| Dr. Marilyn R. Carlson | Chief Medical Officer |
| Mr. Christopher Quesenberry | Chief Commercial Officer - Gimoti (TM) |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0332 |
| Price-to-Sales TTM: | 3.0482 |
| IPO Date: | 2013-09-25 |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |